US 11806369
Exosomes and miRNA to treat glaucoma
granted A61KA61K31/4178A61K31/498
Quick answer
US patent 11806369 (Exosomes and miRNA to treat glaucoma) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/4178, A61K31/498, A61K31/5377, A61K31/5575